Moreover, in subcutaneous xenograft tumour models treated with 5‐fluorouracil or/and β‐catenin inhibitor, we found that the tumour volumes of DCLK1‐overexpressing group were substantially decreased (Figure 7F). This evidence concerns the gene DCLK1 and neoplasm.